Cargando...
Impact of serogroup A meningococcal conjugate vaccine for Africa
The introduction of a serogroup A meningococcal conjugate vaccine in the African meningitis belt has been a remarkable success. Meningitis due to the serogroup A meningococcus, previously responsible for most epidemics, has fallen by 99% in vaccinated countries. Success must, however, not distract f...
Guardado en:
| Publicado en: | Human Vaccines & Immunotherapeutics |
|---|---|
| Autor principal: | |
| Formato: | Artículo |
| Publicado: |
Taylor & Francis Group
2018-05-01
|
| Materias: | |
| Acceso en línea: | http://dx.doi.org/10.1080/21645515.2017.1412022 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|